SSNC:NASDAQSS&C Technologies Holdings, Inc. Analysis
Data as of 2026-05-26 - not real-time
$67.04
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SS&C Technologies is trading at $67.04, comfortably above its 30‑day support of $64.51 but still well below the 200‑day SMA of $80.20, indicating a bearish technical backdrop. The stock’s RSI of 45 suggests neutral momentum, while the MACD line sits just above its signal, offering a hint of bullishness. Fundamentally, the company appears undervalued – its forward PE of 8.94 and a DCF‑derived fair value of $70.41 imply roughly a 5% intrinsic upside, and the price‑to‑earnings gap versus the industry average (20.8 vs 39.5) reinforces this view. Revenue is growing at 8.8% YoY, margins are solid (gross 48%, operating 24%), and free cash flow exceeds $1.27 bn, supporting a sustainable dividend yield of 1.61% with a modest 33% payout ratio. The recent $1.5 bn stock repurchase authorization adds a further catalyst, potentially tightening supply and boosting shareholder returns.
Given the blend of growth drivers, attractive valuation metrics, and a stable dividend, the medium‑ to long‑term outlook is positive, though short‑term price pressure may persist amid the broader bearish trend.
Given the blend of growth drivers, attractive valuation metrics, and a stable dividend, the medium‑ to long‑term outlook is positive, though short‑term price pressure may persist amid the broader bearish trend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support but below key moving averages
- Neutral RSI and modest MACD bullish crossover
- Upcoming stock repurchase may limit downside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers and DCF fair value
- Strong revenue growth and expanding free cash flow
- Attractive forward PE and sustainable dividend
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust recurring software revenue across global markets
- Continued cash generation supporting dividend and buybacks
- Strategic positioning in financial‑services and healthcare software
Key Metrics & Analysis
Financial Health
Revenue Growth8.80%
Profit Margin12.65%
P/E Ratio20.8
ROE11.80%
ROA4.53%
Debt/Equity110.67
P/B Ratio2.3
Op. Cash Flow$1.8B
Free Cash Flow$1.3B
Industry P/E39.5
Technical Analysis
TrendBearish
RSI45.5
Support$64.51
Resistance$71.06
MA 20$67.77
MA 50$68.87
MA 200$80.20
MACDBullish
VolumeStable
Fear & Greed Index91.52
Valuation
Fair Value$70.41
Target Price$94.78
Upside/Downside41.37%
GradeUndervalued
TypeBlend
Dividend Yield1.61%
Risk Assessment
Beta0.74
Volatility26.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.